A new platform for ultra-high dose rate radiobiological research using the BELLA PW laser proton beamline

Radiotherapy is the current standard of care for more than 50% of all cancer patients. Improvements in radiotherapy (RT) technology have increased tumor targeting and normal tissue sparing. Radiations at ultra-high dose rates required for FLASH-RT effects have sparked interest in potentially providi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bin, Jianhui, Obst-Huebl, Lieselotte, Mao, Jian-Hua, Nakamura, Kei, Geulig, Laura D., Chang, Hang, Ji, Qing, He, Li, De Chant, Jared, Kober, Zachary, Gonsalves, Anthony J., Bulanov, Stepan, Celniker, Susan E., Schroeder, Carl B., Geddes, Cameron G. R., Esarey, Eric, Simmons, Blake A., Schenkel, Thomas, Blakely, Eleanor A., Steinke, Sven, Snijders, Antoine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795353/
https://www.ncbi.nlm.nih.gov/pubmed/35087083
http://dx.doi.org/10.1038/s41598-022-05181-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795353/
https://www.ncbi.nlm.nih.gov/pubmed/35087083
http://dx.doi.org/10.1038/s41598-022-05181-3

Ejemplares similares